cabozantinib (XL-184),a C-met/VEGF2 Inhibitors.

Tyrosine kinase inhibitors, blocking various signaling pathways.
Post Reply
Feng zhou
New Member
Posts: 28
Joined: Wed Mar 09, 2011 8:21 pm
Location: China

cabozantinib (XL-184),a C-met/VEGF2 Inhibitors.

Post by Feng zhou »

cabozantinib (XL-184),a C-met/VEGF2 Inhibitors. have a high efficiency for bone metastases

http://www.exelixis.com/cabozantinib/bo ... s/MET-VEGF
http://www.exelixis.com/sites/default/f ... A90%29.pdf
http://www.exelixis.com/sites/default/f ... 84-RDT.pdf
Top
Post Reply

Return to “TKI”